T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses (2020)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2020.09.28.20202929

Publication URI: http://dx.doi.org/10.1101/2020.09.28.20202929

Type: Preprint